| TGF-β1 blockade of microglial chemotaxis toward Aβ aggregates involves SMAD signaling and down-regulation of CCL5 WC Huang, FC Yen, FS Shie, CM Pan, YJ Shiao, CN Yang, FL Huang, ... Journal of neuroinflammation 7, 1-11, 2010 | 78 | 2010 |
| Oncostatin M modulates the mesenchymal–epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect ML Wang, CM Pan, SH Chiou, WH Chen, HY Chang, OKS Lee, HS Hsu, ... Cancer research 72 (22), 6051-6064, 2012 | 63 | 2012 |
| Targeting human leukocyte antigen G with chimeric antigen receptors of natural killer cells convert immunosuppression to ablate solid tumors SCCDYC Chia-Ing Jan, Shi-Wei Huang, Peter Cano, Jeffrey N Bruce, Yu-Chuan ... Journal for ImmunoTherapy of Cancer 9, e003050, 2021 | 47 | 2021 |
| Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings CM Pan, ML Wang, SH Chiou, HY Chen, CW Wu Oncotarget 7 (37), 60395, 2016 | 43 | 2016 |
| Musashi-1 enhances glioblastoma cell migration and cytoskeletal dynamics through translational inhibition of Tensin3 HY Chen, LT Lin, ML Wang, B Laurent, CH Hsu, CM Pan, WR Jiang, ... Scientific reports 7 (1), 8710, 2017 | 40 | 2017 |
| The role of EpCAM in tumor progression and the clinical prognosis of endometrial carcinoma KC Wen, PL Sung, YT Chou, CM Pan, PH Wang, OKS Lee, CW Wu Gynecologic oncology 148 (2), 383-392, 2018 | 35 | 2018 |
| MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme CM Pan, KH Chan, CH Chen, CI Jan, MC Liu, CM Lin, DY Cho, WC Tsai, ... Cancer letters 493, 133-142, 2020 | 24 | 2020 |
| The PML isoform IV is a negative regulator of nuclear EGFR’s transcriptional activity in lung cancer HY Kuo, YC Chen, HY Chang, JC Jeng, EH Lin, CM Pan, YW Chang, ... Carcinogenesis 34 (8), 1708-1716, 2013 | 20 | 2013 |
| BiTE‐Secreting CAR‐γδT as a Dual Targeting Strategy for the Treatment of Solid Tumors SW Huang, CM Pan, YC Lin, MC Chen, Y Chen, CI Jan, CC Wu, FY Lin, ... Advanced Science 10 (17), 2206856, 2023 | 18 | 2023 |
| The e3 ubiquitin ligase nedd4-1 mediates temozolomide-resistant glioblastoma through pten attenuation and redox imbalance in nrf2–ho-1 axis HY Chuang, LY Hsu, CM Pan, NW Pikatan, VK Yadav, IH Fong, CH Chen, ... International journal of molecular sciences 22 (19), 10247, 2021 | 18 | 2021 |
| New efficient method for hysteroscopic isthmoplasty: four simple steps Lead to a significant improvement in bleeding status CC Huang, SC Chiu, CM Pan, CC Huang, CYY Chang, SC Chao, DY Cho, ... Journal of Clinical Medicine 11 (21), 6541, 2022 | 5 | 2022 |
| Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer MC Chen, MY Hung, CM Pan, SW Huang, CI Jan, YH Li, SC Chiu, ... Cancer Science 114 (7), 2761-2773, 2023 | 2 | 2023 |
| HLA-G specific chimeric antigen receptor, nucleic acid, HLA-G specific chimeric antigen receptor expression plasmid, HLA-G specific chimeric antigen receptor expressing cell … CHO Der-Yang, C Shao-Chih, JAN Chia-Ing, CM Pan, SW Huang US Patent 11,479,611, 2022 | 2 | 2022 |
| Method For Treating Cancer CHO Der-Yang, C Shao-Chih, JAN Chia-Ing, CM Pan, SW Huang US Patent App. 16/390,308, 2020 | 2 | 2020 |
| Anti-tumor antigen nanobody and nucleic acid encoding sequence thereof, and uses of the same CHO Der-Yang, C Shao-Chih, SW Huang, CM Pan, MC Chen, YC Lin, ... US Patent 12,012,454, 2024 | 1 | 2024 |
| Anti-T-cell nanobody and nucleic acid encoding sequence thereof, and uses of the same CHO Der-Yang, C Shao-Chih, SW Huang, CM Pan, MC Chen, YC Lin, ... US Patent 11,795,224, 2023 | | 2023 |
| Immunomodulation and anti-tumor-related nanobody and nucleic acid encoding sequence thereof, and uses of the same CHO Der-Yang, C Shao-Chih, SW Huang, CM Pan, MC Chen, YC Lin, ... US Patent 11,795,227, 2023 | | 2023 |
| Production of exosomes and uses thereof YW Chen, CHO Der-Yang, HY Fang, MY Shie, CM Pan, KAN Kai-Wen, ... US Patent App. 18/060,966, 2023 | | 2023 |
| Anti-immune-checkpoint nanobody and nucleic acid encoding sequence thereof, and uses of the same CHO Der-Yang, C Shao-Chih, SW Huang, CM Pan, MC Chen, YC Lin, ... US Patent 11,685,784, 2023 | | 2023 |
| Multispecific nanobodies chimeric antigen receptor and t-cell engager, nucleic acid, expressing cell thereof, pharmaceutical composition for treating cancer, and method for … CHO Der-Yang, C Shao-Chih, SW Huang, CM Pan, JAN Chia-Ing, ... US Patent App. 17/813,681, 2023 | | 2023 |
